Increased levels of FGF10 are observed in ~10% of human breast cancers [38], and amplification and overexpression of several FGFRs, including FGFR1, FGFR2, and FGFR4, have been observed in breast cancers [39–44]. Here, FGFR2 is linked to breast carcinoma.